This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 12496 results found since Jan 2013.
Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice
CONCLUSIONS: High prevalence of physical limitation, pain, and psychiatric comorbidities were found in OUD patients. Since patients were interested in TC to improve their health outcomes, this low-cost intervention, if proven effective, can be integrated into ongoing MOUD programs to improve health in this population.PMID:37644791 | DOI:10.5055/jom.2023.0790
Source: Journal of Opioid Management - August 30, 2023 Category: Addiction Authors: Pao-Feng Tsai Alison H Oliveto Reid D Landes Michael J Mancino Source Type: research
Patient's perceptions of buprenorphine use receiving treatment for cancer
CONCLUSION: This study identifies patients' knowledge gap regarding BUP products for pain, which gives professionals the opportunity to provide education. This study identified that patients are most worried early on about addiction and stigma when using opioids.PMID:37644786 | DOI:10.5055/jom.2023.0785
Source: Journal of Opioid Management - August 30, 2023 Category: Addiction Authors: Amy Yeung Marina G álvez-Peralta Joy Apopa James Wyland Monika Holbein Source Type: research
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE tablet REMEDYREPACK INC.
Updated Date: Wed, 30 Aug 2023 00:00:00 EDT
Source: DailyMed Drug Label Updates - August 30, 2023 Category: Drugs & Pharmacology Source Type: alerts
BUPRENORPHINE AND NALOXONE film INGENUS PHARMACEUTICALS, LLC
Updated Date: Tue, 29 Aug 2023 00:00:00 EDT
Source: DailyMed Drug Label Updates - August 29, 2023 Category: Drugs & Pharmacology Source Type: alerts
18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies
Few studies investigate the natural history of patients on long-term treatment for opioid use disorder (OUD). We evaluated the long-term efficacy, safety, and tolerability experience of monthly extended-release buprenorphine (BUP-XR) in participants seeking treatment for OUD, via integrated analysis of phase 3 studies.
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Daniel Rutrick, Susan M. Learned, Brent Boyett, David Hassman, Sunita Shinde, Yue Zhao Source Type: research
Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care
The objective of this study is to determine the rate of falsification of UDS testing among patients with OUD in active treatment with buprenorphine via a telehealth provider.
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Rebekah Rollston, Barbara Burke, Scott G. Weiner, Winifred Gallogly, Apryl D. Brandon, Robyn Carter, Brian Clear Source Type: research
Moms With OUD: Improved Infant Care Seen With Use of Prenatal Addiction Meds
(MedPage Today) -- For mothers with opioid use disorder (OUD), the use of medication for their addiction such as buprenorphine or methadone during the prenatal period was associated with improved outcomes in infants, a cross-sectional study showed...
Source: MedPage Today OB/GYN - August 28, 2023 Category: OBGYN Source Type: news
Suspected Buprenorphine-Precipitated Opioid Withdrawal following Intercourse: A Case Report
J Pain Palliat Care Pharmacother. 2023 Aug 28:1-3. doi: 10.1080/15360288.2023.2250344. Online ahead of print.ABSTRACTBuprenorphine, a partial mu-opioid receptor agonist, is a commonly prescribed medication for opioid use disorder (OUD). There is evidence that drugs may enter the male genitourinary tract by an ion-trapping process, based on the lipid solubility and degree of ionization (1). While little is known about the pharmacokinetics of drugs in seminal fluid, pH is thought to play an integral role. Limited evidence exists surrounding cervical absorption of drugs via seminal fluid transmission. This also prompts survey...
Source: Journal of Pain and Palliative Care Pharmacotherapy - August 28, 2023 Category: Palliative Care Authors: Davene Lynch Lyndsey Chitty Brittany Johnson Amie L Hoefnagel Source Type: research
Medication Assisted Treatment Program Policies: Opinions of People in Treatment
This study aims to understand factors that help individuals enter and stay in MAT from the perspective of those in recovery. The patient perspective is vital in efforts to improve care delivery and best support individuals in treatment.METHODS: Survey development was driven by a review of current peer-reviewed literature plus information gained through 3 semi-structured interviews and follow-up discussions with 5 individuals who have lived experience in MAT, termed Participant Advisors. Survey questions focused in part on MAT participants' opinions relating to program policies such as drug testing, relapse protocols, durat...
Source: Primary Care - August 28, 2023 Category: Primary Care Authors: Martha Carter Jennifer Boyd Trey Bennett Adam Baus Source Type: research
Buprenorphine deregulation as an opioid crisis policy response - a comparative analysis between France and the United States - Sud A, Chiu K, Friedman J, Dupouy J.
BACKGROUND: In passing the Maintstreaming Addiction Treatment Act, the United States has abolished its federal X waiver, considered a major barrier to the wider buprenorphine prescribing needed to respond to opioid-related harms. Advocates for this policy ...
Source: SafetyLit - August 28, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
BUPRENORPHINE patch, extended release Teva Pharmaceuticals USA, Inc.
Updated Date: Mon, 28 Aug 2023 00:00:00 EDT
Source: DailyMed Drug Label Updates - August 28, 2023 Category: Drugs & Pharmacology Source Type: alerts
Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma
CONCLUSIONS: We observed significant differences in social representations but not in internalized stigma between the two groups. Moreover, the predictive factors linked to the acceptance of a new SC form of OST suggest a multifactorial combination of elements that will have to be tested in a larger and prospective study delivering long-acting high-dose buprenorphine.PMID:37625937 | DOI:10.1016/j.therap.2023.07.006
Source: Therapie - August 25, 2023 Category: Psychiatry & Psychology Authors: Aur élie Lacroix Victor Puybaret Pierre Vill éger Juliette Zattoni-Leroy Sylvain Cantaloube Catherine Chevalier Philippe Nubukpo Source Type: research
< em > Letter to Editor: < /em > Observations of Deception in Urine Drug Testing
CONCLUSION: Deception can be identified using the metabolite/parent drug ratio.PMID:37625839
Source: Annals of Clinical and Laboratory Science - August 25, 2023 Category: Laboratory Medicine Authors: Agnes Cua Kevin Krock Richard Thomas Amadeo Pesce Source Type: research
